As companies undertake new types of analytics projects that require new skills beyond simple sales reporting, it’s worth revisiting the “build vs. buy” question
The start of the '20s offers the industry an opportunity to build value through new tech., collaborations, clinical validations, and value-based outcomes.
This year’s MedTech Conference celebrated several themes, including a need for diversity, the evolution of innovation, and the changing regulatory environment.
The FDA’s quest to modernize medical device reviews could require manufacturers to rethink their regulatory strategy in getting products through the agency.